Current Illinois CancerCare Clinical Trals

Metastatic


A031702

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors


A031901

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy


Search Again